ROBERT D. BONA, MD

Plain English
This study looked at how a specific surgery, called femoral head ostectomy, helped a Shetland pony mare that had a serious hip injury return to athletic activities. After her surgery, which was done because she had been limping severely, the pony was able to be ridden by children again 18 months later and showed no signs of limping or pain five years after the procedure. This is important because it shows that even small ponies can recover and return to active lives after such significant injuries. Who this helps: This helps pet owners, veterinarians, and equestrian programs for kids.

Plain English
This study looked at the outcomes of emergency abdominal surgery in patients who were undergoing chemotherapy for cancer. Out of 30 patients, 80% needed surgery due to intestinal blockages, and 6.7% had a serious complication called colovesical fistula. The results showed that while there were some complications, 46.7% of patients could continue their chemotherapy afterward, and those who had surgery for intestinal obstruction survived a median of 249 days. Who this helps: This information helps doctors and patients by showing that surgery can be an option during chemotherapy, potentially leading to better survival rates.

Plain English
This study looked at how much radiation (called Average Glandular Dose or AGD) women receive during different types of breast imaging, comparing an older method of measurement to a new one. The research found that the new method reduced the amount of radiation women are exposed to, with decreases in AGD ranging from about 6% to 38%, depending on the imaging equipment and breast thickness used. This is important because less radiation exposure can lower the risk of potential side effects from mammography, leading to safer screening practices. Who this helps: This helps patients undergoing mammography, ensuring they receive safer imaging with less radiation.

Plain English
This study looked at how common joint bleeding is in people with mild hemophilia and found that nearly 30% of the patients had experienced joint bleeds, often without any obvious cause. The most frequent sites for these bleeds were the knee and ankle, and more than a third of patients showed abnormal range of motion in their joints. Understanding these issues is important for improving care and monitoring joint health in mild hemophilia patients. Who this helps: This benefits patients with mild hemophilia and their healthcare providers.

Plain English
This study looked at how different blood samples from people with varying HIV experiences affect the CCR5 protein, which HIV uses to enter cells, and how this influences HIV infection in a type of immune cell called macrophages. The researchers found that all blood samples tested significantly reduced the amount of HIV DNA in these cells, but the level of CCR5 didn't seem to directly impact how much HIV infection occurred. This is important because it suggests that factors other than the CCR5 protein levels play a role in HIV infection, which could help in developing new treatment approaches. Who this helps: This helps researchers and doctors working on HIV therapies.

Plain English
This study looked at a medical imaging technique called coronary computed tomography angiography (CCTA), which helps visualize the coronary arteries. Researchers found that the radiation exposure from this procedure decreased significantly, with average radiation doses dropping from 1158 to 221 mGy·cm for the entire exam, and from 1140 to 204 mGy·cm when only examining the CCTA scan. This reduction in radiation is important because it enhances safety for patients undergoing these common tests. Who this helps: Patients needing heart imaging tests.

Plain English
This study looked at how well a new audio technique called Audio Augmented Virtuality (AAV) makes virtual sounds blend with real sounds in a fully virtual environment. Researchers tested different ways to simulate sound reflections and found that people could hardly tell if a sound was fake or real, with accuracy rates near chance for one method. This matters because it shows that current techniques for creating realistic audio experiences might need improvement to better connect virtual and real worlds. Who this helps: This helps developers of virtual reality and audio technology.

Plain English
The study looked at how strength training affects running mechanics and the energy used while running. Fourteen young, active men were split into two groups: one did 8 weeks of strength training, while the other did not. The strength training group used less energy while running, showing a significant decrease in their metabolic cost of transport, meaning they ran more efficiently, but their running form didn't change much overall. Who this helps: This benefits runners looking to improve their performance and efficiency.

Plain English
Researchers studied a new type of HIV vaccine using a special delivery system called Integrase Defective Lentiviral Vectors (IDLVs) that can trigger strong and lasting immune responses. They found that a specific version of this vaccine, called IDLV-UFO.750, generated higher levels of antibodies in mice and led to long-lasting immune responses in monkeys, with some animals developing the ability to neutralize HIV after receiving a boost. This is important because it shows potential for developing a more effective HIV vaccine that lasts longer and offers better protection. Who this helps: This helps patients at risk for HIV and those living with the virus.

Plain English
This study looked at a new method for using a type of virus, called integrase-defective lentiviral vectors (IDLVs), to deliver cancer vaccines. Researchers found that a single dose of their vaccine could effectively reduce or control tumor growth in mice with lymphoma and melanoma. Specifically, they found that using the human version of a tumor-related protein helped break the immune system's tolerance to the cancer and improved the vaccine's effectiveness. Who this helps: This benefits cancer patients by potentially offering a new and effective treatment option.

Plain English
This study focused on improving a type of viral vector used in vaccines, known as integrase-defective lentiviral vectors (IDLVs), to make them safer and more effective. Researchers tested changes in the vector design on mice and found that while a certain alteration did not impact the vector's ability to integrate into the genome, removing another part significantly decreased its effectiveness in generating an immune response. This matters because enhancing the safety and effectiveness of vaccines can lead to better immunization strategies. Who this helps: This research benefits vaccine developers and researchers aiming to create safer and more effective vaccines.

Plain English
This study looked at a condition called macrocytosis, which is when red blood cells are larger than normal, in people with Williams-Beuren syndrome (WBS). Researchers analyzed blood samples from 179 individuals with WBS and found that about 35% had at least one instance of macrocytosis. However, the patients weren't anemic, which means their red blood cell counts were still healthy despite their larger size. Who this helps: This information helps doctors treating patients with Williams-Beuren syndrome by guiding them on how to manage mild macrocytosis without unnecessary tests.

Plain English
Researchers studied a new type of vaccine using a modified lentivirus to trigger immune responses against HIV in mice. They found that a specific design of the vaccine successfully activated T-cell responses that could target HIV, with improvements in the production process leading to better results. This discovery is important because it shows potential for developing a more effective HIV vaccine. Who this helps: This benefits patients at risk for HIV and aids in the search for an effective vaccine.

Plain English
This study looked at a protein called SAMHD1, which usually helps the body fight off viruses. Researchers found that when cells were infected with human cytomegalovirus (HCMV), SAMHD1 levels increased, but this only slightly affected the amount of virus produced. They discovered that the HCMV infection caused SAMHD1 to change and move out of the cell nucleus into the cytoplasm, which may help the virus evade the body's defenses. Who this helps: This research primarily benefits doctors and scientists working on treatments for viral infections, particularly those related to HCMV.

Plain English
This study examined whether dental cleaning leads to serious infections in cancer patients with central venous catheters (CVCs). Researchers found that while 36% of the patients showed a temporary presence of bacteria in their blood immediately after the cleaning, these bacteria did not cause any lasting infections. Importantly, there were no infections linked to the CVCs from the dental cleaning, indicating it's safe for patients who have a certain level of white blood cells. Who this helps: This helps cancer patients with CVCs and their healthcare providers.

Plain English
This study explored a new type of vaccine delivery system using a modified virus that doesn't integrate into the host's DNA. Researchers tested how well this system could deliver parts of the flu virus (specifically two proteins, HA and NP) to stimulate an immune response in mice. They found that mice receiving the new vaccine showed strong and long-lasting antibody levels against the H1N1 flu virus, similar to, or better than, traditional vaccine methods, with effective protection lasting up to 18 weeks after the boost. Who this helps: This benefits patients by potentially improving flu vaccination strategies.

Plain English
This study focused on how the malaria-causing parasite, Plasmodium falciparum, responds to certain drugs in its mature sexual stages called gametocytes. Researchers found that these mature gametocytes are very sensitive to a drug called methylene blue, especially when combined with another treatment that affects their metabolic processes. This is important because it highlights a potential target for new malaria treatments that could help reduce transmission from humans to mosquitoes. Who this helps: This information benefits patients and healthcare providers by informing strategies to combat malaria transmission.

Plain English
In this study, researchers examined a 13-year-old horse in Italy that died from a brain infection thought to be caused by the West Nile virus. They found a parasite called Halicephalobus gingivalis in the horse's brain, specifically identifying the organisms that caused the infection. This is important because understanding how this parasite affects horses can help track its spread and potential risks to human health. Who this helps: This helps veterinarians and horse owners by providing insights into neurological diseases in horses.

Plain English
This study looked at the effects of measuring a blood test (INR) daily versus less often for hospitalized patients taking warfarin, a blood thinner. It found that among over 8,500 patients, those who didn't have their INR measured for two or more days were more likely to experience harmful effects from warfarin, especially cardiac and surgical patients, with odds of 1.48 and 1.73, respectively. Regular checks can help prevent dangerous rises in INR levels, which leads to better patient safety during hospital stays. Who this helps: This helps patients taking warfarin, especially those with heart conditions or who are undergoing surgery.

Plain English
This study examined a new way to create calibration curves for measuring radiation doses using radiochromic films. The new method performs just as well as older methods, achieving a dose accuracy of about 1.5% and reducing the impact of different film batches and scanning settings. This improvement matters because it makes the process of measuring radiation more consistent and reliable, which is essential for ensuring patient safety during treatments. Who this helps: Patients undergoing radiation therapy.

Plain English
This research paper looks at conditions that make blood clotting more likely, known as hypercoagulable states. It discusses two types: inherited conditions, like factor V Leiden, which are passed down through families and increase the risk of blood clots, and acquired conditions that can occur due to factors like cancer. Understanding these conditions is important because they can lead to serious complications during oral surgeries, making it crucial for oral surgeons to be aware of them. Who this helps: This helps oral surgeons and their patients who may have these blood clotting issues.

Plain English
This research developed a new tool using Excel to check how accurate radiation doses are in cancer treatments, specifically by comparing doses from a special film to those calculated by treatment planning software. The tool showed that the dose errors were very small, less than 2% for one type of measurement and less than 3% for another, meaning it could reliably verify treatment plans. This is important because it helps ensure that patients receive the correct amount of radiation, improving the safety and effectiveness of their treatment. Who this helps: This helps patients receiving radiation therapy.

Plain English
This study looked at how a molecule called CCL2 affects the replication of HIV-1, a virus that targets immune cells called macrophages. Researchers found that blocking CCL2 significantly reduced HIV-1 replication, showing an impressive drop in the number of infected cells and limiting viral DNA accumulation. This matters because it uncovers a new way to enhance the body's natural defenses against HIV, potentially leading to better treatments for people living with the virus. Who this helps: Patients with HIV.

Plain English
Researchers studied a protein called TM9SF4 and its role in how colon cancer cells manage their pH levels, which affects their ability to spread and resist treatment. They found that reducing TM9SF4 levels led to a more normal pH environment for the cancer cells, resulting in a significant decrease in their invasiveness and making them more sensitive to a common chemotherapy drug, 5-fluorouracil. This matters because targeting TM9SF4 could help in developing new treatments for colon cancer. Who this helps: Patients with colon cancer.

Plain English
This study focused on improving the testing methods for finding new drugs against malaria, specifically targeting the stage of the parasite that spreads from humans to mosquitoes. The researchers developed a new dual-color test that measures the effects of drugs on different stages of the malaria parasite more efficiently, achieving a reliability score of 0.71, and allowing tests to be completed in just 48 hours with lower costs. These advancements are crucial because faster and cheaper tests can lead to the quicker development of new treatments for malaria. Who this helps: This helps researchers and healthcare professionals working on malaria treatments.

Plain English
This study looked at how a specific type of vaccine (an integrase defective lentiviral vector or IDLV carrying a protein called ovalbumin) could generate strong immune responses in mice when given through an injection in the muscle, either alone or along with a protein taken under the tongue. The researchers found that a single muscle injection created lasting responses in key immune cells, especially in the intestines, and when followed by the sublingual (under the tongue) protein boost, it sharply increased important antibodies in the blood and saliva. This is significant because it shows a promising way to create vaccines that effectively protect against infections at both the body surface and deeper tissues. Who this helps: This benefits patients by improving vaccination strategies to protect against infections.

Plain English
Researchers tested whether a protein called murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) could boost the immune response in mice vaccinated with a viral vector carrying a green protein used as a model. They found that adding mGM-CSF did not enhance the immune response, measured by specific immune cells and markers, compared to the vaccination without it. This matters because understanding which components can effectively improve vaccine responses is crucial for developing better vaccines in the future. Who this helps: This helps vaccine developers and researchers working on improving immune responses in vaccinations.

Plain English
Researchers developed a new method to extract a type of natural plastic, called short-chain-length poly(hydroxyalkanoates) (scl-PHA), from tiny organisms using acetone at high temperatures and pressure. This new method effectively matches traditional methods in terms of purity (98.4% compared to 97.7%) and yield (96.8% for both), but it is much faster, taking only 20 minutes instead of 12 hours. This is important because it allows for quicker and more efficient recycling of a sustainable material. Who this helps: This benefits companies looking to produce bio-based plastics efficiently.

Plain English
The study looked at how a medication called raltegravir affects specific circular pieces of HIV DNA in patients with active and suppressed viral infections. Researchers found that raltegravir increases the amount of these circular DNA pieces in the blood, and this effect is different for patients who have the virus actively replicating compared to those who do not. This information is important because it helps us understand how raltegravir works in the body and could guide better treatment strategies for managing HIV. Who this helps: This helps patients with HIV and their doctors make informed treatment decisions.

Plain English
This paper discusses guidelines for treating and preventing heparin-induced thrombocytopenia (HIT), a serious reaction to the blood thinner heparin that can cause dangerous blood clots. The researchers recommended monitoring platelet counts every 2-3 days for patients at risk for HIT and suggested using specific anticoagulants (like argatroban) for those who develop HIT and need treatment. These guidelines help doctors manage HIT effectively, reducing the risk of life-threatening complications for patients. Who this helps: Patients at risk of heparin-related complications.

Plain English
This study looked at a 56-year-old woman with multiple myeloma who developed severe heart failure after receiving bortezomib, a drug commonly used to treat her condition. The woman's heart function was severely impacted, with only 25% efficiency, and she showed signs of fluid around the heart and problems with heart valves. This is significant because it highlights a serious potential side effect of bortezomib that has been rarely reported before, emphasizing the need for doctors to monitor heart health closely in patients receiving this treatment. Who this helps: This helps patients with multiple myeloma and their doctors by raising awareness of potential heart risks associated with bortezomib.

Plain English
This study looked at how well virus-like particles (VLPs) can be used to create vaccines by incorporating large proteins from viruses like hepatitis C and influenza. The researchers found that VLPs carrying these large proteins triggered strong immune responses in mice and human cells, especially a type of immune cell known as CD8+ T cells. This matters because it shows that this method of designing vaccines could be effective for larger proteins, paving the way for improved vaccines against various infections. Who this helps: This helps patients at risk for hepatitis C and influenza by offering potentially more effective vaccine options.

Plain English
Researchers explored a new type of vaccine called integrase-defective lentiviral vectors (IDLV) to see how well it can trigger strong immune responses. They found that a single dose of IDLV led to powerful and lasting immune responses in mice, specifically improving the action of T cells that fight infections. This is important because it suggests IDLV could be a more effective way to develop vaccines in the future. Who this helps: This helps patients by potentially improving vaccine effectiveness against diseases.

Plain English
This study focused on exploring dabigatran, a new oral medication for patients with atrial fibrillation (AF), particularly to prevent strokes and other serious blood clots. Researchers found that dabigatran effectively reduces the occurrence of strokes and blood clots, similarly to the older drug warfarin, but with easier dosing and no need for routine blood tests. While patients using dabigatran may face some gastrointestinal issues and there is a slight increase in the risk of bleeding, its overall cost-effectiveness makes it a viable option compared to warfarin. Who this helps: This benefits patients with atrial fibrillation who need blood thinning treatments.

Plain English
This study looked at how a specific protein, gp96/grp94, is crucial for creating a complex that helps platelets function properly. Researchers found that when this protein is missing, it leads to very low platelet counts and larger platelets in mice, similar to a condition in humans called Bernard-Soulier Syndrome (BSS). Understanding this relationship is important because it can help develop treatments for related blood disorders. Who this helps: This helps patients with blood disorders, particularly those with Bernard-Soulier Syndrome.

Plain English
This study looked at a new method for using a type of virus (called integrase-defective lentiviral vectors, or IDLVs) to help expand immune cells known as CD8(+) T cells, which are important for fighting infections like the flu. Researchers found that using IDLVs to infect human immune cells led to a significant growth of these T cells in the lab, showing that this method can effectively boost immune responses against specific infections. This is important because it shows a potential new way to improve vaccines and therapies for various diseases. Who this helps: This helps patients who need stronger immune responses, especially those with viral infections or cancer.

Plain English
Researchers created new virus-like particles (VLPs) using lentivirus technology to deliver proteins for research and vaccine development. They discovered that certain HIV-1 proteins could be efficiently combined with other proteins, allowing the VLPs to carry large proteins up to 630 amino acids long. This work is important because it opens up new ways to deliver proteins, which can lead to advancements in medical research and treatments. Who this helps: This benefits researchers and scientists working on vaccines and protein-based therapies.

Plain English
This study looked at different methods for using genetic information to determine the right dose of warfarin, a common but tricky blood thinner to manage. Researchers tested four existing algorithms and one new method with 1,095 patients, finding that while all algorithms were similarly effective overall, the best one (from the IWPC) accurately predicted the correct dose for about 46% of patients. This research is important because it highlights that no single algorithm is best for everyone, and doctors may need to consider their specific patient populations when deciding which method to use. Who this helps: This helps doctors and patients who need warfarin management.

Plain English
The study focused on how different types of genetic vaccines affect the immune response in mice, specifically targeting a key immune cell called CD8+ T cells. Researchers found that a vaccine using a nonintegrating lentiviral vector was more effective than a traditional DNA vaccine in triggering a strong and lasting immune response. Specifically, there was a higher presence of CD8+ T cells that could produce multiple immune signals, indicating a robust response. Who this helps: This research benefits vaccine developers and patients needing effective treatments for cancers and viral infections.

Plain English
This study looked at how well certain medications that target HIV integrase work against human immune cells called macrophages, which are important for HIV infection. Researchers tested various integrase inhibitors and found that some were effective even against a mutant form of the virus that usually resists treatment. This is important because it helps in developing new medications that can work better against resistant strains of HIV. Who this helps: This benefits patients living with HIV, particularly those with resistant strains of the virus.

Plain English
This research examined how a protein called gp96 helps other proteins known as Toll-like receptors (TLRs) fold correctly in cells. The study found that gp96 requires another protein, CNPY3, to effectively assist several TLRs (but not TLR3), and if the interaction between gp96 and CNPY3 is disrupted, the TLRs cannot fold properly. This is important because correctly functioning TLRs play a key role in the immune system, so understanding their folding process can lead to better insights into immune responses and potential therapies. Who this helps: This helps patients, particularly those with immune-related conditions.

Plain English
This study looked at a new way to connect the pancreas to the intestine after surgery to remove part of the pancreas and duodenum. Researchers found that none of the 27 patients developed a pancreatic leak, which is a common and serious problem after this type of surgery. This method, using special patches to reinforce the connections, seems effective in preventing leaks and complications, making it an important advancement in pancreatic surgery. Who this helps: Patients undergoing pancreaticoduodenectomy.

Plain English
This study looked at how immune cells called dendritic cells (DC) interacted with cells infected by HIV. Researchers found that when DC made direct contact with HIV-infected cells, they absorbed the virus much more effectively—up to several times stronger than without direct contact. This absorption helped the DC present more pieces of the virus to other immune cells, potentially improving the body's ability to fight HIV. Who this helps: This benefits patients with HIV by enhancing understanding of their immune response.

Plain English
The study focused on a new type of vaccine using a modified virus that can't integrate into the host's DNA. Researchers tested this vaccine on mice and found that it successfully triggered strong and long-lasting immune responses. Specifically, they demonstrated this by measuring important immune markers 90 days after vaccination, showing that the new vaccine worked as well as the standard type but with higher safety and no DNA integration. Who this helps: This benefits researchers and eventually patients at risk for HIV, as it could lead to safer vaccines.

Plain English
This research focused on a drug called 17-AAG, which targets a protein called HSP90 that helps certain cancers grow. The studies showed that 17-AAG can significantly reduce tumor growth in various cancers, particularly in advanced multiple myeloma, and two major clinical trials are currently underway to confirm its effectiveness. Understanding and improving how this drug works could lead to better cancer treatments. Who this helps: Patients with cancers like multiple myeloma.

Plain English
This study focused on how certain medications, called HIV protease inhibitors, affect the spread of HIV in specific immune cells known as dendritic cells. The researchers discovered that these inhibitors significantly reduce the ability of these cells to take in and spread the virus; specifically, they found a dramatic decrease in "trans-infection" activity, where one infected cell spreads HIV to others. This is important because it helps us understand how HIV spreads and suggests new ways to develop treatments that could prevent infections. Who this helps: This helps patients at risk of HIV and doctors looking for better prevention methods.